Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GIK solution
DRUG
3 trials
Sponsors
Yonsei University
, NYU Langone Health
, Sohag University
Conditions
Acute Aluminum Phosphide Poisoned Cases
Acute Coronary Syndrome
Femoral Shaft Fracture
Tibial Shaft Fracture
Phase 2
MAGIK for Femoral/Tibial Shaft Fractures
Withdrawn
NCT05627479
NYU Langone Health
Femoral Shaft Fracture, Tibial Shaft Fracture
Start: 2024-12-01
End: 2027-01-01
Updated: 2025-03-06
Phase 4
Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome
Completed
NCT01384656
Yonsei University
Acute Coronary Syndrome
Start: 2011-02-28
End: 2012-02-29
Updated: 2013-03-06
Unknown Phase
Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.
Not yet recruiting
NCT07451561
Sohag University
Acute Aluminum Phosphide Poisoned Cases
Start: 2026-03-01
End: 2027-03-01
Target: 74
Updated: 2026-03-05
Related Papers
Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery.
2012-09-17
13 citations